Sarah Cannon Research Institute
Nicole Gregory, BSRS, has extensive experience in the medical imaging field, currently serving as Clinical Team Lead II at Sarah Cannon Research Institute since January 2017, with a progression through various roles including Clinical Team Lead I and Sr. Clinical Project Associate. Prior to this, Nicole worked at HCA in various capacities, including CT Technologist, and also gained experience at Vanderbilt University Medical Center as a CT Technologist. Nicole's education includes a Bachelor of Science in Radiologic Technology from Pima Medical Institute-Tucson and an Associate of Applied Science from Fortis Institute in Nashville. Proficient in advanced radiographic procedures, Nicole has a strong background in patient care, interdepartmental cooperation, and equipment handling, while also contributing to student mentorship and classroom leadership during earlier educational roles.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.